Cell cycle proteins in epithelial cell differentiation Implications for breast cancer

被引:69
作者
Caldon, C. Elizabeth [1 ]
Sutherland, Robert L. [1 ,2 ]
Musgrove, Elizabeth A. [1 ,2 ]
机构
[1] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia
[2] Univ NSW, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia
关键词
differentiation; cell cycle; proliferation; mammary gland; breast cancer; cyclin D1; Rb; alveologenesis; ACTIVATED-RECEPTOR-GAMMA; MAMMARY-GLAND DEVELOPMENT; KINASE INHIBITOR P27(KIP1); GROWTH-FACTOR-BETA; GENE-EXPRESSION; VITAMIN-D; TRANSCRIPTION FACTOR; PPAR-GAMMA; C/EBP-BETA; NEURONAL DIFFERENTIATION;
D O I
10.4161/cc.9.10.11474
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Proliferation and differentiation are tightly coupled processes, so that a final cell cycle is often linked to the initiation of cell differentiation. The flux in cell cycle proteins during this process is commonly assumed to simply control the final cell cycle exit. However it now appears that cell cycle proteins can also play a role in the decision to continue cycling or to terminally differentiate. A subset of the G 1 to S phase transition proteins, D-type cyclins, Rb family proteins and the CDK inhibitors, are particularly involved in the commitment to differentiation. Cell cycle proteins can sequester or modify activators of differentiation pathways, while simultaneously performing their cell cycle functions as illustrated by their roles in terminal differentiation in mammary epithelium. G 1 to S phase cell cycle proteins, particularly cyclin D1, are commonly altered in breast cancer and contribute to breast tumorigenesis, presumably by increasing proliferation. However the capacity for cell cycle proteins to also influence differentiation may influence tumour progression, and may alter the efficacy of differentiation-based therapeutics.
引用
收藏
页码:1918 / 1928
页数:11
相关论文
共 157 条
[1]   Cdk4 promotes adipogenesis through PPARγ activation [J].
Abella, A ;
Dubus, P ;
Malumbres, M ;
Rane, SG ;
Kiyokawa, H ;
Sicard, A ;
Vignon, F ;
Langin, D ;
Barbacid, M ;
Fajas, L .
CELL METABOLISM, 2005, 2 (04) :239-249
[2]   p27 deregulation in breast cancer: Prognostic significance and implications for therapy [J].
Alkarain, A ;
Jordan, R ;
Slingerland, J .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2004, 9 (01) :67-80
[3]  
Alle KM, 1998, CLIN CANCER RES, V4, P847
[4]   The promise of retinoids to fight against cancer [J].
Altucci, L ;
Gronemeyer, H .
NATURE REVIEWS CANCER, 2001, 1 (03) :181-193
[5]   Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation [J].
Bartkova, J ;
Lukas, J ;
Strauss, M ;
Bartek, J .
ONCOGENE, 1998, 17 (08) :1027-1037
[6]  
Bartkova J, 1996, INT J CANCER, V65, P323, DOI 10.1002/(SICI)1097-0215(19960126)65:3<323::AID-IJC8>3.0.CO
[7]  
2-1
[8]   Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription [J].
Batsché, E ;
Moschopoulos, P ;
Desroches, J ;
Bilodeau, S ;
Drouin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :16088-16095
[9]   p21WAF1/CIP1 acts as a brake in osteoblast differentiation [J].
Bellosta, P ;
Masramon, L ;
Mansukhani, A ;
Basilico, C .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) :818-826
[10]   Binding of pRB to the PHD protein RBP2 promotes cellular differentiation [J].
Benevolenskaya, EV ;
Murray, HL ;
Branton, P ;
Young, RA ;
Kaelin, WG .
MOLECULAR CELL, 2005, 18 (06) :623-635